Advertisement
Screener

NIAGEN BIOSCIENCE, INC. (NAGE) Sales Revenue, Goods, Net (Deprecated 2018-01-31)

2.5 / 5 stars · 44/89 Roast Me

NIAGEN BIOSCIENCE, INC. Sales Revenue, Goods, Net (Deprecated 2018-01-31)

NIAGEN BIOSCIENCE, INC. (NAGE) reported Sales Revenue, Goods, Net (Deprecated 2018-01-31) of $6.57 million for the 3-month period ending 2018-03-31, per its 10-Q filed 2018-05-10.

Discontinued › Expense Statement › Operating Expenses

us-gaap:SalesRevenueGoodsNet · last filed 2018-05-10

  • NIAGEN BIOSCIENCE, INC. sales revenue, goods, net (deprecated 2018-01-31) for the quarter ending 2018-03-31 was $6.57M, a 94.98% increase year-over-year.
  • NIAGEN BIOSCIENCE, INC. sales revenue, goods, net (deprecated 2018-01-31) for the quarter ending 2017-12-30 was $7.53M, a 69.13% increase year-over-year.
  • NIAGEN BIOSCIENCE, INC. sales revenue, goods, net (deprecated 2018-01-31) for the quarter ending 2017-09-30 was $6.08M, a 54.54% increase year-over-year.
  • NIAGEN BIOSCIENCE, INC. sales revenue, goods, net (deprecated 2018-01-31) for the quarter ending 2017-07-01 was $4.22M, a 43.17% decline year-over-year.
  • NIAGEN BIOSCIENCE, INC. sales revenue, goods, net (deprecated 2018-01-31) for fiscal 2017 was $21.20M, a 2.14% decline from fiscal 2016.
  • NIAGEN BIOSCIENCE, INC. sales revenue, goods, net (deprecated 2018-01-31) for fiscal 2016 was $21.66M, a 21.13% increase from fiscal 2016.
  • NIAGEN BIOSCIENCE, INC. sales revenue, goods, net (deprecated 2018-01-31) for fiscal 2016 was $17.88M, a 16.79% increase from fiscal 2015.
  • NIAGEN BIOSCIENCE, INC. sales revenue, goods, net (deprecated 2018-01-31) for fiscal 2015 was $15.31M, a 50.71% increase from fiscal 2013.
Period endSales Revenue, Goods, Net (Deprecated 2018-01-31) 3 monthSales Revenue, Goods, Net (Deprecated 2018-01-31) 3 month as first filedSales Revenue, Goods, Net (Deprecated 2018-01-31) 6 monthSales Revenue, Goods, Net (Deprecated 2018-01-31) 9 monthSales Revenue, Goods, Net (Deprecated 2018-01-31) 9 month as first filedSales Revenue, Goods, Net (Deprecated 2018-01-31) 12 monthSales Revenue, Goods, Net (Deprecated 2018-01-31) 12 month as first filedSales Revenue, Goods, Net (Deprecated 2018-01-31) 18 month
2018-03-31$6.57M
10-Q · filed 2018-05-10
$14.10M
derived: sum of 2 quarters · filed 2018-05-10
$20.18M
derived: sum of 3 quarters · filed 2018-05-10
$24.40M
derived: sum of 4 quarters · filed 2018-05-10
2017-12-30$7.53M
10-K · filed 2018-03-15
$13.62M
derived: sum of 2 quarters · filed 2018-03-15
$17.83M
derived: sum of 3 quarters · filed 2018-03-15
$21.20M
10-K · filed 2018-03-15
2017-09-30$6.08M
10-K · filed 2018-03-15
$10.30M
derived: sum of 2 quarters · filed 2018-03-15
$13.67M
10-Q · filed 2017-11-09
$18.12M
derived: sum of 4 quarters · filed 2018-05-10
2017-07-01$4.22M
10-K · filed 2018-03-15
$5.31M
10-Q · filed 2017-08-10
$9.76M
10-Q · filed 2017-08-10
$12.04M
derived: sum of 3 quarters · filed 2018-05-10
$15.98M
derived: sum of 4 quarters · filed 2018-05-10
2017-04-01$3.37M
10-Q · filed 2018-05-10
$4.45M
10-Q · filed 2017-05-11
$7.82M
derived: sum of 2 quarters · filed 2018-05-10
$11.76M
derived: sum of 3 quarters · filed 2018-05-10
$19.18M
derived: sum of 4 quarters · filed 2018-05-10
2016-12-31$4.45M
10-K · filed 2018-03-15
$5.64M
10-K · filed 2017-03-16
$8.39M
derived: sum of 2 quarters · filed 2018-03-15
$15.81M
derived: sum of 3 quarters · filed 2018-03-15
$21.66M
10-K · filed 2018-03-15
$26.81M
10-K · filed 2017-03-16
2016-10-01$3.94M
10-K · filed 2018-03-15
$5.01M
10-Q · filed 2016-11-10
$11.36M
derived: sum of 2 quarters · filed 2018-03-15
$17.21M
10-Q · filed 2017-11-09
$21.17M
10-Q · filed 2016-11-10
$21.58M
derived: sum of 4 quarters · filed 2018-03-15
2016-07-02$7.42M
10-K · filed 2018-03-15
$8.83M
10-Q · filed 2016-08-11
$16.16M
10-Q · filed 2017-08-10
$17.64M
derived: sum of 3 quarters · filed 2018-03-15
$23.93M
derived: sum of 4 quarters · filed 2018-03-15
2016-04-02$5.85M
10-K · filed 2018-03-15
$7.33M
10-Q · filed 2016-05-12
$10.22M
derived: sum of 2 quarters · filed 2018-03-15
$16.50M
derived: sum of 3 quarters · filed 2018-03-15
$22.61M
derived: sum of 4 quarters · filed 2018-03-15
2016-01-02$4.36M
10-K · filed 2017-03-16
$10.65M
derived: sum of 2 quarters · filed 2017-03-16
$16.75M
derived: sum of 3 quarters · filed 2017-03-16
$17.88M
10-K · filed 2018-03-15
$22.01M
10-K · filed 2016-03-17
2015-10-03$6.29M
10-K · filed 2017-03-16
$12.39M
derived: sum of 2 quarters · filed 2017-03-16
$17.65M
10-Q · filed 2016-11-10
$21.89M
derived: sum of 4 quarters · filed 2017-03-16
2015-07-04$6.10M
10-K · filed 2017-03-16
$11.36M
10-Q · filed 2016-08-11
$15.61M
derived: sum of 3 quarters · filed 2017-03-16
$19.75M
derived: sum of 4 quarters · filed 2017-03-16
2015-04-04$5.26M
10-K · filed 2017-03-16
$9.50M
derived: sum of 2 quarters · filed 2017-03-16
$13.64M
derived: sum of 3 quarters · filed 2017-03-16
$17.50M
derived: sum of 4 quarters · filed 2017-03-16
2015-01-03$4.24M
10-K · filed 2017-03-16
$8.38M
derived: sum of 2 quarters · filed 2017-03-16
$12.24M
derived: sum of 3 quarters · filed 2017-03-16
$15.31M
10-K · filed 2017-03-16
2014-09-27$4.14M
10-K · filed 2017-03-16
$8.00M
derived: sum of 2 quarters · filed 2017-03-16
$11.07M
10-Q · filed 2015-11-12
$13.47M
derived: sum of 4 quarters · filed 2017-03-16
2014-06-28$3.86M
10-K · filed 2017-03-16
$6.93M
10-Q · filed 2015-08-13
$9.33M
derived: sum of 3 quarters · filed 2017-03-16
$12.05M
derived: sum of 4 quarters · filed 2017-03-16
2014-03-29$3.07M
10-K · filed 2017-03-16
$5.48M
derived: sum of 2 quarters · filed 2017-03-16
$8.19M
derived: sum of 3 quarters · filed 2017-03-16
$10.90M
derived: sum of 4 quarters · filed 2017-03-16
2013-12-28$2.40M
10-K · filed 2016-03-17
$5.12M
derived: sum of 2 quarters · filed 2016-03-17
$7.83M
derived: sum of 3 quarters · filed 2016-03-17
$10.16M
10-K · filed 2016-03-17
2013-09-28$2.72M
10-K · filed 2016-03-17
$5.43M
derived: sum of 2 quarters · filed 2016-03-17
$7.76M
10-Q · filed 2014-11-06
$11.28M
derived: sum of 4 quarters · filed 2016-03-17
2013-06-29$2.71M
10-Q · filed 2014-08-12
$5.04M
10-Q · filed 2014-08-12
$8.56M
derived: sum of 3 quarters · filed 2016-03-17
$12.20M
derived: sum of 4 quarters · filed 2016-03-17
2013-03-30$2.33M
10-K · filed 2016-03-17
$5.86M
derived: sum of 2 quarters · filed 2016-03-17
$9.49M
derived: sum of 3 quarters · filed 2016-03-17
$12.16M
derived: sum of 4 quarters · filed 2016-03-17
2012-12-29$3.52M
derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-27
$7.15M
derived: sum of 2 quarters · filed 2014-03-27
$9.83M
derived: sum of 3 quarters · filed 2014-03-27
$11.61M
10-K · filed 2014-03-27
2012-09-29$3.63M
10-Q · filed 2013-11-21
$6.30M
derived: sum of 2 quarters · filed 2013-12-05
$8.09M
10-Q · filed 2013-11-21
$9.90M
derived: sum of 4 quarters · filed 2013-12-05
2012-07-02$4.48M
10-Q · filed 2012-08-09
2012-06-30$2.67M
10-Q/A · filed 2013-12-05
$4.46M
10-Q/A · filed 2013-12-05
$6.26M
derived: sum of 3 quarters · filed 2013-12-05
$8.09M
derived: sum of 4 quarters · filed 2013-12-05
2012-03-31$1.79M
10-Q/A · filed 2013-12-05
$3.59M
derived: sum of 2 quarters · filed 2013-12-05
$5.42M
derived: sum of 3 quarters · filed 2013-12-05
$7.36M
derived: sum of 4 quarters · filed 2013-12-05
2011-12-31$1.81M
derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-29
$3.64M
derived: sum of 2 quarters · filed 2013-03-29
$5.57M
derived: sum of 3 quarters · filed 2013-03-29
$8.11M
10-K · filed 2013-03-29
2011-10-01$1.83M
10-Q · filed 2012-11-08
$3.77M
derived: sum of 2 quarters · filed 2012-11-08
$6.30M
10-Q · filed 2012-11-08
2011-07-02$1.94M
10-Q/A · filed 2012-08-10
$4.48M
10-Q/A · filed 2012-08-10
2011-04-02$2.54M
10-Q · filed 2012-05-10
2011-01-01$7.57M
10-K · filed 2012-03-15

Similar stocks

Stock NameCountryMarket CapPE Ratio
USANA HEALTH SCIENCES INC (USNA)United States$0.264B-17.90
FITLIFE BRANDS, INC. (FTLF)United States$0.087B16.59
Canopy Growth Corp (CGC)$0.395B
MANNATECH INC (MTEX)United States$0.014B
NATURAL ALTERNATIVES INTERNATIONAL INC (NAII)United States$0.011B-1.16
Synergy CHC Corp. (SNYR)United States$0.001B
Functional Brands Inc. (MEHA)United States$0.001B
Tilray Brands, Inc. (TLRY)United States$0.554B-5.97
Cronos Group Inc. (CRON)$1.223B
Definium Therapeutics, Inc. (DFTX)United States$4.931B-17.87